New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis
J. bras. pneumol; 44 (2), 2018
ABSTRACT Multidrug-resistant and extensively drug-resistant tuberculosis (MDR-TB and XDR-TB, respectively) continue to represent a challenge for clinicians and public health authorities. Unfortunately, although there have been encouraging reports of higher success rates, the overall rate of favorable out...